An Overview and New Treatment Options for Amyloid … June/1115-1245... · 2020-01-21 · An...
Transcript of An Overview and New Treatment Options for Amyloid … June/1115-1245... · 2020-01-21 · An...
![Page 1: An Overview and New Treatment Options for Amyloid … June/1115-1245... · 2020-01-21 · An Overview and New Treatment Options for Amyloid Cardiomyopathy Andrew M. Kates, MD, FACC](https://reader033.fdocuments.in/reader033/viewer/2022050202/5f5603e7fded064b5c3cf1a2/html5/thumbnails/1.jpg)
An Overview and New Treatment Options for Amyloid Cardiomyopathy
Andrew M. Kates, MD, FACC
Professor of Medicine
Director, Cardiology Fellowship Program
Washington University School of Medicine
St. Louis, MO
![Page 2: An Overview and New Treatment Options for Amyloid … June/1115-1245... · 2020-01-21 · An Overview and New Treatment Options for Amyloid Cardiomyopathy Andrew M. Kates, MD, FACC](https://reader033.fdocuments.in/reader033/viewer/2022050202/5f5603e7fded064b5c3cf1a2/html5/thumbnails/2.jpg)
Amyloidosis
British Journal of Haematology, 2001, 114, 529±538
![Page 3: An Overview and New Treatment Options for Amyloid … June/1115-1245... · 2020-01-21 · An Overview and New Treatment Options for Amyloid Cardiomyopathy Andrew M. Kates, MD, FACC](https://reader033.fdocuments.in/reader033/viewer/2022050202/5f5603e7fded064b5c3cf1a2/html5/thumbnails/3.jpg)
Types of Amyloid – Systemic
• Light chain (AL)
• “Primary”
• AL-CA
• Transthyretin (ATTR) • Hereditary (Familial/FAP)
• Wild type (Senile)
• ATTR-CA
• Serum amyloid A (AA) – “Secondary”
![Page 4: An Overview and New Treatment Options for Amyloid … June/1115-1245... · 2020-01-21 · An Overview and New Treatment Options for Amyloid Cardiomyopathy Andrew M. Kates, MD, FACC](https://reader033.fdocuments.in/reader033/viewer/2022050202/5f5603e7fded064b5c3cf1a2/html5/thumbnails/4.jpg)
Mechanisms of Amyloid Protein Cardiotoxicity
Falk, R et al. J Am Coll Cardiol. 2016;68:1323-1341
![Page 5: An Overview and New Treatment Options for Amyloid … June/1115-1245... · 2020-01-21 · An Overview and New Treatment Options for Amyloid Cardiomyopathy Andrew M. Kates, MD, FACC](https://reader033.fdocuments.in/reader033/viewer/2022050202/5f5603e7fded064b5c3cf1a2/html5/thumbnails/5.jpg)
Natural History of Cardiac Amyloidosis
![Page 6: An Overview and New Treatment Options for Amyloid … June/1115-1245... · 2020-01-21 · An Overview and New Treatment Options for Amyloid Cardiomyopathy Andrew M. Kates, MD, FACC](https://reader033.fdocuments.in/reader033/viewer/2022050202/5f5603e7fded064b5c3cf1a2/html5/thumbnails/6.jpg)
Amyloidosis: Diagnosis
“The only way to diagnose amyloidosis is to consider the
diagnosis.”
![Page 7: An Overview and New Treatment Options for Amyloid … June/1115-1245... · 2020-01-21 · An Overview and New Treatment Options for Amyloid Cardiomyopathy Andrew M. Kates, MD, FACC](https://reader033.fdocuments.in/reader033/viewer/2022050202/5f5603e7fded064b5c3cf1a2/html5/thumbnails/7.jpg)
Amyloidosis: Clinical Features
• GI: • Dysphagia, malabsorption, GI
bleeding
• Constipation, nausea, liver dysfunction (alk phos elevation)
• Soft tissue/ENT • Macroglossia, carpal tunnel
syndrome
• Voice changes, nail changes
• Cardiac • Heart failure, arrhythmias
• Hypotension, imaging abnormalities
• Renal • Proteinuria, renal failure
• Neurologic • Peripheral neuropathy,
autonomic dysfunction
![Page 8: An Overview and New Treatment Options for Amyloid … June/1115-1245... · 2020-01-21 · An Overview and New Treatment Options for Amyloid Cardiomyopathy Andrew M. Kates, MD, FACC](https://reader033.fdocuments.in/reader033/viewer/2022050202/5f5603e7fded064b5c3cf1a2/html5/thumbnails/8.jpg)
Cardiac Manifestations
• Heart failure • Diastolic dysfunction (impaired relaxation) > Systolic dysfunction (impaired contraction)
• Electrophysiologic • Heart block
• Tachyarrhythmias
• Low voltages on EKG
• Imaging/Laboratory • Left ventricular “hypertrophy”
• Elevated troponin/BNP/NT proBNP
![Page 9: An Overview and New Treatment Options for Amyloid … June/1115-1245... · 2020-01-21 · An Overview and New Treatment Options for Amyloid Cardiomyopathy Andrew M. Kates, MD, FACC](https://reader033.fdocuments.in/reader033/viewer/2022050202/5f5603e7fded064b5c3cf1a2/html5/thumbnails/9.jpg)
Typical Imaging Characteristics in Amyloidosis
![Page 10: An Overview and New Treatment Options for Amyloid … June/1115-1245... · 2020-01-21 · An Overview and New Treatment Options for Amyloid Cardiomyopathy Andrew M. Kates, MD, FACC](https://reader033.fdocuments.in/reader033/viewer/2022050202/5f5603e7fded064b5c3cf1a2/html5/thumbnails/10.jpg)
Adjunctive Laboratory Tests
• SPEP • Monoclonal immunoglobulins in serum
• UPEP • Monoclonal light chains in urine
• Free light chain assay (SFLC) • Measures ratio of k to l in serum
• Normal ratio: Approximately 1:1
• Significant excess: Implies monoclonal light chain production
• Main assay to assess hematologic response to Rx
• BNP/NT proBNP
• Troponin I/T
• Alkaline phosphatase
• Urine albumin: Cr ratio
• TTR amyloidosis: Genetic testing
![Page 11: An Overview and New Treatment Options for Amyloid … June/1115-1245... · 2020-01-21 · An Overview and New Treatment Options for Amyloid Cardiomyopathy Andrew M. Kates, MD, FACC](https://reader033.fdocuments.in/reader033/viewer/2022050202/5f5603e7fded064b5c3cf1a2/html5/thumbnails/11.jpg)
How to Diagnose – Biopsy! • Cannot be excluded with lab assessment
alone
• Technetium-pyrophosphate scans may be helpful
• Our general practice: • Biopsy of clinically involved organ
• Testing for amyloid subtype – plan ahead! • Know pathologist
• Congo Red
• Immunofluorescence if light chains are present
• Mass spectrometry (sent to Mayo)
• Organ (Sensitivity) • Abdominal fat pad “70%” (?)
• Bone marrow 50-56%
• Rectal 70-85%
• Clinically involved organ Nearly 100%
![Page 12: An Overview and New Treatment Options for Amyloid … June/1115-1245... · 2020-01-21 · An Overview and New Treatment Options for Amyloid Cardiomyopathy Andrew M. Kates, MD, FACC](https://reader033.fdocuments.in/reader033/viewer/2022050202/5f5603e7fded064b5c3cf1a2/html5/thumbnails/12.jpg)
Endomyocardial Biopsy?
• No tissue biopsy confirmation/and a definitive diagnosis is needed
• Positive biopsy for amyloid from noncardiac site • Uncertain ATTR genotype
• Familial ATTR genotype but confounding information
• Patients considered for cardiac transplantation
• Hemodynamic assessment for medical management
• Can usually be avoided • Suspected familial/wild-type ATTR amyloid w positive radionuclide scan/SFLC ratio
• ATTR genotype from peripheral blood /saliva can aid in identifying known mutation
• AL amyloid -Dx can often be made with a combination of SFLC and extracardiac biopsy
![Page 13: An Overview and New Treatment Options for Amyloid … June/1115-1245... · 2020-01-21 · An Overview and New Treatment Options for Amyloid Cardiomyopathy Andrew M. Kates, MD, FACC](https://reader033.fdocuments.in/reader033/viewer/2022050202/5f5603e7fded064b5c3cf1a2/html5/thumbnails/13.jpg)
Treatment: Cardiac-Specific
• Diuretics/salt restriction • Often have large amounts of peripheral edema/ascites
• Made worse by hypoalbuminemia
• To generally be avoided: • Digoxin
• Beta-blockers
• Calcium-blockers
• Vasodilators (ACE-I/ARBs) unless proteinuria is a prominent feature
• Midodrine/Droxidopa • Can be useful in orthostatic hypotension
• Treatment of atrial & ventricular arrhythmias
![Page 14: An Overview and New Treatment Options for Amyloid … June/1115-1245... · 2020-01-21 · An Overview and New Treatment Options for Amyloid Cardiomyopathy Andrew M. Kates, MD, FACC](https://reader033.fdocuments.in/reader033/viewer/2022050202/5f5603e7fded064b5c3cf1a2/html5/thumbnails/14.jpg)
Therapeutic approaches to AL -CA
![Page 15: An Overview and New Treatment Options for Amyloid … June/1115-1245... · 2020-01-21 · An Overview and New Treatment Options for Amyloid Cardiomyopathy Andrew M. Kates, MD, FACC](https://reader033.fdocuments.in/reader033/viewer/2022050202/5f5603e7fded064b5c3cf1a2/html5/thumbnails/15.jpg)
Therapeutic approaches to ATTR - CA
![Page 16: An Overview and New Treatment Options for Amyloid … June/1115-1245... · 2020-01-21 · An Overview and New Treatment Options for Amyloid Cardiomyopathy Andrew M. Kates, MD, FACC](https://reader033.fdocuments.in/reader033/viewer/2022050202/5f5603e7fded064b5c3cf1a2/html5/thumbnails/16.jpg)
APOLLO – Hereditary with polyneuropathy
![Page 17: An Overview and New Treatment Options for Amyloid … June/1115-1245... · 2020-01-21 · An Overview and New Treatment Options for Amyloid Cardiomyopathy Andrew M. Kates, MD, FACC](https://reader033.fdocuments.in/reader033/viewer/2022050202/5f5603e7fded064b5c3cf1a2/html5/thumbnails/17.jpg)
![Page 18: An Overview and New Treatment Options for Amyloid … June/1115-1245... · 2020-01-21 · An Overview and New Treatment Options for Amyloid Cardiomyopathy Andrew M. Kates, MD, FACC](https://reader033.fdocuments.in/reader033/viewer/2022050202/5f5603e7fded064b5c3cf1a2/html5/thumbnails/18.jpg)
ATTRACT – Wild type and mutation
![Page 19: An Overview and New Treatment Options for Amyloid … June/1115-1245... · 2020-01-21 · An Overview and New Treatment Options for Amyloid Cardiomyopathy Andrew M. Kates, MD, FACC](https://reader033.fdocuments.in/reader033/viewer/2022050202/5f5603e7fded064b5c3cf1a2/html5/thumbnails/19.jpg)
![Page 20: An Overview and New Treatment Options for Amyloid … June/1115-1245... · 2020-01-21 · An Overview and New Treatment Options for Amyloid Cardiomyopathy Andrew M. Kates, MD, FACC](https://reader033.fdocuments.in/reader033/viewer/2022050202/5f5603e7fded064b5c3cf1a2/html5/thumbnails/20.jpg)
Circulation. 2017;135:1357–1377.
![Page 21: An Overview and New Treatment Options for Amyloid … June/1115-1245... · 2020-01-21 · An Overview and New Treatment Options for Amyloid Cardiomyopathy Andrew M. Kates, MD, FACC](https://reader033.fdocuments.in/reader033/viewer/2022050202/5f5603e7fded064b5c3cf1a2/html5/thumbnails/21.jpg)
Current strategies
• Clinical awareness and early diagnosis are critical
• Cardiac amyloidosis results from distinctive disease processes • Differing treatment strategies and prognoses
• Initial presentation is insidious • LVH on imaging is commonly the first phenotypic abnormality
• Optimal treatment varies greatly from the usual treatment of HF
• Many potential targets for therapies
• New therapies are in development and now available
![Page 22: An Overview and New Treatment Options for Amyloid … June/1115-1245... · 2020-01-21 · An Overview and New Treatment Options for Amyloid Cardiomyopathy Andrew M. Kates, MD, FACC](https://reader033.fdocuments.in/reader033/viewer/2022050202/5f5603e7fded064b5c3cf1a2/html5/thumbnails/22.jpg)
Amyloidosis Center of Excellence (ACE) @ Wash U
• Cardiology
• Neurology
• Nephrology
• Gastroenterology
• Hepatology
• BMT
• Hematology
• Pulmonology
• Radiology
• Pathology
Multidisciplinary Team
![Page 23: An Overview and New Treatment Options for Amyloid … June/1115-1245... · 2020-01-21 · An Overview and New Treatment Options for Amyloid Cardiomyopathy Andrew M. Kates, MD, FACC](https://reader033.fdocuments.in/reader033/viewer/2022050202/5f5603e7fded064b5c3cf1a2/html5/thumbnails/23.jpg)
![Page 24: An Overview and New Treatment Options for Amyloid … June/1115-1245... · 2020-01-21 · An Overview and New Treatment Options for Amyloid Cardiomyopathy Andrew M. Kates, MD, FACC](https://reader033.fdocuments.in/reader033/viewer/2022050202/5f5603e7fded064b5c3cf1a2/html5/thumbnails/24.jpg)
Amyloid
fibrils
Oligomers
SAP
Proteotoxicity
Misfolded light chain
Interactions with cells &
microenvironment
(GAGs, metals, proteases, shear
forces) of target organs
Organ dysfunction
and reduced survival
Plasma cell clone
o Heart 76% • (NYHA≥II, 47%)
o Kidney 68%
• Nephrotic s.
42%
• Renal failure
45%
o Liver 15%
o GI 8%
o Soft tissues 17%
o PNS/ANS 12%/10%
Immunoglobulin light chain amyloidosis (AL)
Adapted from Merlini
![Page 25: An Overview and New Treatment Options for Amyloid … June/1115-1245... · 2020-01-21 · An Overview and New Treatment Options for Amyloid Cardiomyopathy Andrew M. Kates, MD, FACC](https://reader033.fdocuments.in/reader033/viewer/2022050202/5f5603e7fded064b5c3cf1a2/html5/thumbnails/25.jpg)
Kumar, S et al JCO 2012
Staging for AL Amyloidosis
Using 1 point for each cutoff:
TnT > 0.025
NTproBNP >1800
Free Light chain> 18mg/dL
![Page 26: An Overview and New Treatment Options for Amyloid … June/1115-1245... · 2020-01-21 · An Overview and New Treatment Options for Amyloid Cardiomyopathy Andrew M. Kates, MD, FACC](https://reader033.fdocuments.in/reader033/viewer/2022050202/5f5603e7fded064b5c3cf1a2/html5/thumbnails/26.jpg)
Confidential. Internal Use Only. 26
Clinical presentation of ATTR-CM can have cardiovascular or neurological origins
Cardiovascular
Most common signs
Heart Failure* Atrial Fibrillation
Fatigue
Dizziness
Shortness of breath
Edema
Chest pain
Peripheral Neuropathy Autonomic Neuropathy
Diarrhea
Weight loss
Orthostatic
hypotension
Excessive sweating
Erectile dysfunction
Neurological
Tingling
Numbness
Myalgia and burning
sensations
Weakness
Carpal tunnel
syndrome
Most common signs
1. Nakagawa M et al. Amyloid. 2016;23(1):58–63. 3. Gertz MA et al. JACC. 2015;66(21):2451-2466.
![Page 27: An Overview and New Treatment Options for Amyloid … June/1115-1245... · 2020-01-21 · An Overview and New Treatment Options for Amyloid Cardiomyopathy Andrew M. Kates, MD, FACC](https://reader033.fdocuments.in/reader033/viewer/2022050202/5f5603e7fded064b5c3cf1a2/html5/thumbnails/27.jpg)
Diagnosis of TTR Cardiac Amyloidosis
Circulation. 2016;133:2404-2412.
DOI: 10.1161/CIRCULATIONAHA.116.021612.
![Page 28: An Overview and New Treatment Options for Amyloid … June/1115-1245... · 2020-01-21 · An Overview and New Treatment Options for Amyloid Cardiomyopathy Andrew M. Kates, MD, FACC](https://reader033.fdocuments.in/reader033/viewer/2022050202/5f5603e7fded064b5c3cf1a2/html5/thumbnails/28.jpg)
European Heart Journal (2018) 39, 2799–2806
doi:10.1093/eurheartj/ehx589
Proposed staging for ATTR
Cutoffs:
• NTproBNP >3000 ng/L
• EGFR <45ml/min/1.73m2
• If both negative= Stage I
• If both present= Stage III
![Page 29: An Overview and New Treatment Options for Amyloid … June/1115-1245... · 2020-01-21 · An Overview and New Treatment Options for Amyloid Cardiomyopathy Andrew M. Kates, MD, FACC](https://reader033.fdocuments.in/reader033/viewer/2022050202/5f5603e7fded064b5c3cf1a2/html5/thumbnails/29.jpg)
![Page 30: An Overview and New Treatment Options for Amyloid … June/1115-1245... · 2020-01-21 · An Overview and New Treatment Options for Amyloid Cardiomyopathy Andrew M. Kates, MD, FACC](https://reader033.fdocuments.in/reader033/viewer/2022050202/5f5603e7fded064b5c3cf1a2/html5/thumbnails/30.jpg)
![Page 31: An Overview and New Treatment Options for Amyloid … June/1115-1245... · 2020-01-21 · An Overview and New Treatment Options for Amyloid Cardiomyopathy Andrew M. Kates, MD, FACC](https://reader033.fdocuments.in/reader033/viewer/2022050202/5f5603e7fded064b5c3cf1a2/html5/thumbnails/31.jpg)
amyloidosis.org
Our key priorities:
• Raising awareness in the medical field for an earlier diagnosis.
• Educating medical professionals through our Grand Rounds program and attendance at medical conferences.
• Empowering patients through our comprehensive range of services, including accurate up to date information.